Home › Funds › ORBIMED ADVISORS LLC › QTTB

ORBIMED ADVISORS LLC position in QTTB

Q32 Bio Inc · Health Care

ORBIMED ADVISORS LLC reported holding 4,127,987 shares of QTTB (Q32 Bio Inc) in its Q2 2026 13F filing — a position valued at US$52.6M, representing 1.06% of its reported portfolio and ranking #30 among its reported holdings. ORBIMED ADVISORS LLC has disclosed QTTB holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)4.13M sh
Reported value held$52.59M
Portfolio Weight1.06%
First reportedQ1 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ORBIMED ADVISORS LLC's QTTB position evolved

ORBIMED ADVISORS LLC first disclosed a stake in QTTB in Q1 2024 at 2,252,987 shares (US$38.4M). The position peaked in Q3 2024 at 2,252,987 shares, worth US$100.5M. Across 10 filings, ORBIMED ADVISORS LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 8 time(s). The most recent filing (Q2 2026) shows 4,127,987 shares valued at US$52.6M — an increase of 1,875,000 shares quarter over quarter.. Notable position changes include a 83% increase in Q2 2026 (shares fell 35% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 2.25M $38.39M New
Q2 2024 2.25M $40.44M Hold
Q3 2024 2.25M $100.53M Hold
Q4 2024 2.25M $7.75M Hold
Q1 2025 2.25M $3.72M Hold
Q2 2025 2.25M $3.36M Hold
Q3 2025 2.25M $4.46M Hold
Q4 2025 2.25M $7.48M Hold
Q1 2026 2.25M $14.46M Hold
Q2 2026 4.13M $52.59M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About QTTB and 13F data

QTTB (Q32 Bio Inc) is a Health Care company. 50 other funds we track also report a position in QTTB — the largest reported positions include Boxer Capital Management, LLC (US$40.1M), Atlas Venture Life Science Advisors, LLC (US$34.6M), BVF INC/IL (US$29.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding QTTB

All QTTB fund holders →

FAQ

How long has ORBIMED ADVISORS LLC held QTTB?

ORBIMED ADVISORS LLC has disclosed QTTB holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is ORBIMED ADVISORS LLC's current position in QTTB?

As of Q2 2026, ORBIMED ADVISORS LLC holds 4.13M shares of QTTB (Q32 Bio Inc), valued at $52.59M, representing 1.06% of its reported portfolio and ranking #30.

Has ORBIMED ADVISORS LLC been buying or selling QTTB?

In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC increased its position in QTTB. The position peaked in Q3 2024 at 2.25M shares.

Which other funds hold QTTB?

Other major institutional holders of QTTB include Boxer Capital Management, LLC, Atlas Venture Life Science Advisors, LLC, BVF INC/IL, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.